A Fixed Dose Study of Ropinirole Prolonged Release as Adjunctive Treatment in Patients With Advanced Parkinson's Disease

NCT01494532 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

352

Enrollment

INDUSTRY

Sponsor class

Conditions

Parkinson Disease

Interventions

DRUG: ropinirole/L-dopa
DRUG: placebo/L-dopa

Sponsor

GlaxoSmithKline